02 Nov 22

Azadyne, a biotech startup targeting autoimmune disease wins o2h discovery kickstarter competition

31 Oct 22

o2h group is supporting upcoming Biotech Bikers’ event Nov 2022

03 Oct 22

Kuano Limited, a quantum simulation led biotech company wins o2h discovery kick-starter competitio

25 Aug 22

o2h discovery is exhibiting at the XXVII EFMC ISMC International Symposium on Medicinal Chemistry

08 Aug 22

o2h group is supporting the upcoming Biotech Bikers’ event 2022

05 Aug 22

o2h discovery launches the o2h kickstarter competition to support early stage biotechs’

21 Jul 22

o2h discovery is sponsoring and exhibiting at the 3rd Molecules Medicinal Chemistry Symposium R

29 Jun 22

o2h group is supporting the BiotechBikers’ event 2022

12 May 22

o2h co-work Lab Launches World’s First Influencer Tech Bootcamp

04 May 22

Stingray Bio and o2h discovery initiate a collaboration to develop the next-generation of oncology

03 May 22

o2h group acquires 40,000 sq ft Hauxton Meadows site in Cambridge, UK with plans to develop state-

21 Apr 22

Claudio Dagostin will be representing o2h discovery at the 33rd Medicinal Chemistry Meeting

12 Apr 22

Prashant Shah, CEO of o2h co work labs and Co-Founder of o2h group shortlisted in the Cambridge In

23 Mar 22

o2h discovery is exhibiting at the 8th RSC-BMCS Fragment-based Drug Discovery Meeting – 2022

25 Jan 22

o2h group is attending BIA Gala Dinner 2022

27 Dec 21

Data sharing made easy with Chemistry in the Cloud (CITC)

13 Dec 21

o2h Ventures is hosting Jingle Chai – A Fireside Chat with Sir Mene Pangalos

09 Nov 21

ImmuNext and o2h discovery collaborate to progress first-in-class drug discovery programs

02 Nov 21

o2h co work labs Hosted the World’s First Influencer Biotech Bootcamp…

15 Oct 21

o2h discovery is exhibiting at the ElRIG UK’s annual conference Drug Discovery 2021

08 Oct 21

o2h Ventures “Human Health SEIS Fund” Invests into Sanome…

27 Sep 21

o2h co-work Labs Launches the World’s First Influencer Biotech Bootcamp…

02 Sep 21

o2h group is supporting the upcoming BiotechBikers’ networking event in The UK

31 Aug 21

o2h Ventures makes it to the finals in the EISA Awards 2021…

13 Aug 21

o2h Ventures backed In4Derm enters into an exclusive license agreement with VYNE Therapeutics

05 Aug 21

o2h Ventures ‘Knowledge Intensive Human Health EIS Fund’ invests into BiVictriX Therapeutics

21 Jul 21

Digital brain biomarker company Monument Therapeutics raises £2.6 million

05 Jul 21

Neophore closed £15.2m series B round successfully and expands its drug discovery collaboration w

01 Jul 21

o2h Technology appoints serial entrepreneur Fiona Nielsen as Chief Operations Officer

23 Jun 21

o2h group is observing Kindness Day in memory of Shabu Thomas

11 May 21

o2h Ventures backed In4Derm Announces a Strategic Partnership with a Nasdaq listed biotech with a

16 Apr 21

Sunil Shah, CEO of o2h ventures, wins the Cambridge Independent Science and Technology Awards as C

17 Feb 21

Mill SciTech Park pre-planning application submitted

28 Nov 20

o2h group in the finals of Cambridge Independent Science and Tech Awards 2020

23 Nov 20

Press Release – o2h group accomplished its goal of planting ten thousand trees

12 Nov 20

o2h ventures launches the first HMRC approved knowledge intensive EIS fund focused on UK biotech t

23 Sep 20

o2h discovery is exhibiting at the 3rd RSC-BMCS / RSC-CICAG Artificial Intelligence in Chemistry s

23 Jun 20

o2h group announces Kindness Day in memory of Shabu Thomas

29 May 20

o2h community collaborated with The Ahmedabad Project to plant over 2000 trees

13 Apr 20

Fighting Coronavirus – an update on Remdesivir by Gilead

25 Mar 20

Impacting COVID-19 – Opportunities for Chemists

11 Mar 20

Delighted to Announce the 3rd o2h group collaborative innovation conference

23 Feb 20

o2h community has completed the first stage of its campaign to plant 10,000 trees

16 Jan 20

o2h ventures portfolio company Exonate announces collaboration with Johnson & Johnson

13 Nov 19

Nilesh Dagia, COO, o2h discovery, wins the International Institute for Sustainable Labs (I2SL) Go

11 Nov 19

Sunil Shah, CEO, o2h discovery Wins Special Recognition Award by OBN UK Ltd

22 Oct 19

o2h discovery expands synthetic chemistry collaboration with Sosei Heptares

17 Oct 19

o2h ventures makes it to the finals in the Tax Efficiency Awards

20 Sep 19

Pleased to Announce the 13th Edition of o2h Women’s Open Day

11 Sep 19

Cedilla Therapeutics and o2h discovery are pleased to announce multi FTE expansion to their synthe

12 Aug 19

Chemistry Process Optimization – an inevitable parameter for the developmental phase of the drug

18 Jul 19

o2h ventures Makes an Investment in Small Pharma

15 Jul 19

Q&A with Angel Investor Sunil Shah | The Sunday Times

08 Jul 19

Sunil Shah, o2h ventures wins Angel Investor of the Year

28 Jun 19

Sunil Shah, CEO, o2h ventures, makes it to final in the UKBAA Awards 2019

18 Jun 19

Oxford Drug Design recieves over £8m in grant and equity investment

10 Jun 19

Privitar Raises $40 Million Series B Funding Round Led by Accel to Facilitate the Safe and Ethical

24 May 19

o2h Ventures makes it to the final in the Great EIS 25th Year Anniversary Awards

01 Apr 19

Metrion Biosciences Closes Funding Round- o2h Ventures

29 Mar 19

The o2h Therapeutics and AI Fund makes investment in early stage biotechnology company

28 Mar 19

2% off the initial fee for The o2h Therapeutics and AI S/EIS Fund

28 Mar 19

Press Release – The o2h Therapeutics Fund makes its first investment

08 Mar 19

The o2h Innovation Conference 2019 14th March at Courtyard by Marriott, Ahmedabad

31 Jan 19

o2h ventures limited has now launched the o2h therapeutics fund

18 Oct 18

Arecor secures £6M investment for the clinical development of its diabetes speciality pharma port

22 Jun 18

Press Release – PhoreMost and o2h discovery collaborate to progress first-in-class drug disc

25 May 18

Stemnovate secures funding from angels led by o2h ventures

09 May 18

Press release – o2h group acquires the 2.76 acre heritage Hauxton Mill site, Cambridge, UK w

18 Apr 18

Press Release – Curza and o2h discovery announce a multi-FTE chemistry collaboration against

17 Apr 18

Watch o2h Ventures CEO Sunil Shah feature in the British Business Bank Finance Guide video

15 Mar 18

We are celebrating o2h Collaborative Innovation Conference, Ahmedabad 2018 at 15th March 2018

14 Mar 18

o2h group Innovation day teaser

10 Mar 18

o2h group invites you to Innovation day

02 Nov 17

Chemistry in the Cloud™ – The World’s First App To Project Manage Drug Discover

10 Oct 17

Arecor Announces License Agreement with Global Pharmaceutical Company

04 Oct 17

IOTA Pharmaceuticals in £1.5M WINDOW Consortium Tackling Glioblastoma

10 Aug 17

o2h group to attend these upcoming conferences

24 Jul 17

Exonate receives UK Angel Investment Award

31 May 17

o2h ventures update: Oxford Drug Design secures £1.5M financing

13 May 17

o2h group update: Exonate receives Wellcome Trust funding to develop eye drop treatment for wet ag

02 Nov 16

o2h discovery is pleased to announce a 10 FTE Synthetic Chemistry collaboration with Heptares

16 Oct 16

Orfan Biotech, a company dedicated to developing small molecules for the treatment of Primary Hype

16 Oct 16

o2h discovery are working with new Boston based start-up Arrakis, supporting discovery efforts and

26 Sep 16

o2h community volunteers visit “Jeevan Dhara” – Old age home, Ahmedabad, India.

28 Sep 15

o2h community, Community Service Project, HIV Orphanage, Ahmedabad, India.

26 Apr 15

Investment in the seed round of Phoremost who have developed a next-generation phenotypic screenin

07 Apr 15

Happy 10th Birthday o2h group

14 Jul 11

o2h discovery Announces Expanded Chemistry Collaboration With Heptares